| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cutting Edge |
* Basic Research Program, SAIC-Frederick, and
Laboratory of Genomic Diversity, National Cancer Institute, Frederick, MD 21702;
Toronto Western Research Institute and Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, and
Regional HLA Laboratory, University Health Network, Toronto, Ontario, Canada; and
¶ Immunology Division, Department of Pathology, University of Cambridge, Cambridge, United Kingdom
NK cell activity is partially controlled through interactions between killer Ig-like receptors (KIR) on NK cells and their respective HLA class I ligands. Independent segregation of HLA and KIR genes, along with KIR specificity for particular HLA allotypes, raises the possibility that any given individual may express KIR molecules for which no ligand is present. Inhibitory receptor genes KIR2DL2/3 and KIR2DL1 were present in nearly all subjects sampled in this study, whereas their respective activating homologs, KIR2DS2 and KIR2DS1, are each present in about half of the subjects. In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing. Absence of ligands for inhibitory KIRs could potentially lower the threshold for NK (and/or T) cell activation mediated through activating receptors, thereby contributing to pathogenesis of psoriatic arthritis.
This article has been cited by other articles:
|
|
 |
|
  D. P. Lowe, M. A. Cook, S. J. Bowman, D. C. Briggs, and the UK Sjogren's Interest Group Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome Rheumatology, April 1, 2009; 48(4): 359 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Fodil-Cornu, S.-H. Lee, S. Belanger, A. P. Makrigiannis, C. A. Biron, R. M. Buller, and S. M. Vidal Ly49h-Deficient C57BL/6 Mice: A New Mouse Cytomegalovirus-Susceptible Model Remains Resistant to Unrelated Pathogens Controlled by the NK Gene Complex J. Immunol., November 1, 2008; 181(9): 6394 - 6405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Toloza, F. Pellett, V Chandran, D Ibanez, M. Urowitz, and D. Gladman Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus Lupus, September 1, 2008; 17(9): 793 - 798. [Abstract] [PDF]
|
|
|
|
|
|
L. A. Guethlein, A. M. Older Aguilar, L. Abi-Rached, and P. Parham Evolution of Killer Cell Ig-Like Receptor (KIR) Genes: Definition of an Orangutan KIR Haplotype Reveals Expansion of Lineage III KIR Associated with the Emergence of MHC-C J. Immunol., July 1, 2007; 179(1): 491 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. A. Huynh, T. Hampartzoumian, J. P. Arm, J. Hunt, L. Borges, M. Ahern, M. Smith, C. L. Geczy, H. P. McNeil, and N. Tedla Down-regulation of leucocyte immunoglobulin-like receptor expression in the synovium of rheumatoid arthritis patients after treatment with disease-modifying anti-rheumatic drugs Rheumatology, May 1, 2007; 46(5): 742 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mullally and J. Ritz Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation Blood, February 15, 2007; 109(4): 1355 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Campillo, J. A. Martinez-Escribano, M. R. Moya-Quiles, L. A. Marin, M. Muro, N. Guerra, A. Parrado, M. Campos, J. F. Frias, A. Minguela, et al. Natural Killer Receptors on CD8 T Cells and Natural Killer Cells from Different HLA-C Phenotypes in Melanoma Patients. Clin. Cancer Res., August 15, 2006; 12(16): 4822 - 4831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Boyton, J. Smith, R. Ward, M. Jones, L. Ozerovitch, R. Wilson, M. Rose, J. Trowsdale, and D. M. Altmann HLA-C and Killer Cell Immunoglobulin-like Receptor Genes in Idiopathic Bronchiectasis Am. J. Respir. Crit. Care Med., February 1, 2006; 173(3): 327 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cook, D. Briggs, C. Craddock, P. Mahendra, D. Milligan, C. Fegan, P. Darbyshire, S. Lawson, E. Boxall, and P. Moss Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation Blood, February 1, 2006; 107(3): 1230 - 1232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hayashi, K. Imai, Y. Morishita, I. Hayashi, Y. Kusunoki, and K. Nakachi Identification of the NKG2D Haplotypes Associated with Natural Cytotoxic Activity of Peripheral Blood Lymphocytes and Cancer Immunosurveillance Cancer Res., January 1, 2006; 66(1): 563 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Butsch Kovacic, M. Martin, X. Gao, T. Fuksenko, C.-J. Chen, Y.-J. Cheng, J.-Y. Chen, R. Apple, A. Hildesheim, and M. Carrington Variation of the Killer Cell Immunoglobulin-Like Receptors and HLA-C Genes in Nasopharyngeal Carcinoma Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2673 - 2677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kuroki, N. Tsuchiya, M. Shiroishi, L. Rasubala, Y. Yamashita, K. Matsuta, T. Fukazawa, M. Kusaoi, Y. Murakami, M. Takiguchi, et al. Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis Hum. Mol. Genet., August 15, 2005; 14(16): 2469 - 2480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Azuz-Lieberman, G. Markel, S. Mizrahi, R. Gazit, J. Hanna, H. Achdout, R. Gruda, G. Katz, T. I. Arnon, S. Battat, et al. The involvement of NK cells in ankylosing spondylitis Int. Immunol., July 1, 2005; 17(7): 837 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Xu, A. N. Vallejo, Y. Jiang, C. M. Weyand, and J. J. Goronzy Distinct Transcriptional Control Mechanisms of Killer Immunoglobulin-like Receptors in Natural Killer (NK) and in T Cells J. Biol. Chem., June 24, 2005; 280(25): 24277 - 24285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Abi-Rached and P. Parham Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues J. Exp. Med., April 18, 2005; 201(8): 1319 - 1332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Carrington, S. Wang, M. P. Martin, X. Gao, M. Schiffman, J. Cheng, R. Herrero, A. C. Rodriguez, R. Kurman, R. Mortel, et al. Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci J. Exp. Med., April 4, 2005; 201(7): 1069 - 1075. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. van Bergen, A. Thompson, A. van der Slik, T. H. M. Ottenhoff, J. Gussekloo, and F. Koning Phenotypic and Functional Characterization of CD4 T Cells Expressing Killer Ig-Like Receptors J. Immunol., December 1, 2004; 173(11): 6719 - 6726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Hiby, J. J. Walker, K. M. O'Shaughnessy, C. W.G. Redman, M. Carrington, J. Trowsdale, and A. Moffett Combinations of Maternal KIR and Fetal HLA-C Genes Influence the Risk of Preeclampsia and Reproductive Success J. Exp. Med., October 18, 2004; 200(8): 957 - 965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Nelson, M. P. Martin, D. Gladman, J. Wade, J. Trowsdale, and M. Carrington Cutting Edge: Heterozygote Advantage in Autoimmune Disease: Hierarchy of Protection/Susceptibility Conferred by HLA and Killer Ig-Like Receptor Combinations in Psoriatic Arthritis J. Immunol., October 1, 2004; 173(7): 4273 - 4276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Snyder, T. Nakajima, P. J. Leibson, C. M. Weyand, and J. J. Goronzy Stimulatory Killer Ig-Like Receptors Modulate T Cell Activation through DAP12-Dependent and DAP12-Independent Mechanisms J. Immunol., September 15, 2004; 173(6): 3725 - 3731. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. I. Khakoo, C. L. Thio, M. P. Martin, C. R. Brooks, X. Gao, J. Astemborski, J. Cheng, J. J. Goedert, D. Vlahov, M. Hilgartner, et al. HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection Science, August 6, 2004; 305(5685): 872 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Katz, R. Gazit, T. I. Arnon, T. Gonen-Gross, G. Tarcic, G. Markel, R. Gruda, H. Achdout, O. Drize, S. Merims, et al. MHC Class I-Independent Recognition of NK-Activating Receptor KIR2DS4 J. Immunol., August 1, 2004; 173(3): 1819 - 1825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Saruhan-Direskeneli, F. A. Uyar, A. Cefle, S. C. Onder, E. Eksioglu-Demiralp, S. Kamali, M. Inanc, L. Ocal, and A. Gul Expression of KIR and C-type lectin receptors in Behcet's disease Rheumatology, April 1, 2004; 43(4): 423 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Cook, D. W. Milligan, C. D. Fegan, P. J. Darbyshire, P. Mahendra, C. F. Craddock, P. A. H. Moss, and D. C. Briggs The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia Blood, February 15, 2004; 103(4): 1521 - 1526. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Rajalingam, P. Parham, and L. Abi-Rached Domain Shuffling Has Been the Main Mechanism Forming New Hominoid Killer Cell Ig-Like Receptors J. Immunol., January 1, 2004; 172(1): 356 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. van der Slik, B. P.C. Koeleman, W. Verduijn, G. J. Bruining, B. O. Roep, and M. J. Giphart KIR in Type 1 Diabetes: Disparate Distribution of Activating and Inhibitory Natural Killer Cell Receptors in Patients Versus HLA-Matched Control Subjects Diabetes, October 1, 2003; 52(10): 2639 - 2642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Martin, A. Bashirova, J. Traherne, J. Trowsdale, and M. Carrington Cutting Edge: Expansion of the KIR Locus by Unequal Crossing Over J. Immunol., September 1, 2003; 171(5): 2192 - 2195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Saulquin, L. N. Gastinel, and E. Vivier Crystal Structure of the Human Natural Killer Cell Activating Receptor KIR2DS2 (CD158j) J. Exp. Med., April 7, 2003; 197(7): 933 - 938. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Cooper, L. L. Lanier, M. E. Conley, and J. M. Puck Immunodeficiency Disorders Hematology, January 1, 2003; 2003(1): 314 - 330. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
